Philippe Menu Sells Shares of SOPH $SOPH
Key Points
- Philippe Menu sold 5,000 shares of SOPHiA GENETICS SA ($SOPH) worth $24,750.
- $SOPH last traded around $4.88.
Philippe Menu, Chief Medical Officer at SOPHiA GENETICS SA ($SOPH), sold 5,000 shares at an average price of $4.95, for a total transaction of $24,750. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
SOPHiA GENETICS SA ($SOPH) Stock
SOPHiA GENETICS SA Earnings
Analysts Set New Price Targets
About SOPHiA GENETICS SA
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company has a partnership with Synnovis to bring blood-based cancer testing to patients in the United Kingdom. The company was incorporated in 2011 and is based in Rolle, Switzerland.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.